Success Metrics

Clinical Success Rate
66.7%

Based on 8 completed trials

Completion Rate
67%(8/12)
Active Trials
1(6%)
Results Posted
63%(5 trials)
Terminated
4(25%)

Phase Distribution

Ph phase_2
7
44%
Ph not_applicable
1
6%
Ph phase_4
5
31%
Ph phase_1
1
6%
Ph phase_3
1
6%

Phase Distribution

1

Early Stage

7

Mid Stage

6

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
7(46.7%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
5(33.3%)
N/ANon-phased studies
1(6.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

8 of 14 finished

Non-Completion Rate

42.9%

6 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(8)
Terminated(6)
Other(1)

Detailed Status

Completed8
Terminated4
Withdrawn2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 27 (46.7%)
Phase 31 (6.7%)
Phase 45 (33.3%)
N/A1 (6.7%)

Trials by Status

terminated425%
completed850%
unknown16%
withdrawn213%
recruiting16%

Recent Activity

1 active trials
Showing 5 of 16
recruitingphase_2

Regulation of Endogenous Glucose Production by Central KATP Channels

NCT03540758
terminatedphase_4

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

NCT03608163
terminatedphase_2

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

NCT03566511
terminatedphase_4

Central Mechanisms That Regulate Glucose Metabolism in Humans

NCT01028846
withdrawnphase_2

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

NCT03685773
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT03540758Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Recruiting
NCT03608163Phase 4

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

Terminated
NCT03566511Phase 2

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

Terminated
NCT01028846Phase 4

Central Mechanisms That Regulate Glucose Metabolism in Humans

Terminated
NCT03685773Phase 2

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Withdrawn
NCT02779257Phase 4

Pasireotide Treatment for Neuroendocrine Tumor

Withdrawn
NCT01488136Phase 4

Use of Diazoxide in Acute Hypoglycaemia

Completed
NCT00892073Phase 2

Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy

Completed
NCT02049385Phase 1

Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?

Terminated
NCT00683774Not Applicable

Insulin and Polycystic Ovary Syndrome

Completed
NCT00631033Phase 2

DZX Mediated Insulin Suppression in Obese Men

Completed
NCT00131755Phase 4

Efficacy of Diazoxide in Type 1 Diabetes

Completed
NCT00306683Phase 3

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Completed
NCT00994149Phase 2

Diazoxide In the Management Of Hypoglycemic Neonates

Unknown
NCT00151684Phase 2

Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men

Completed
NCT00184821

Ischemic Injury and Ischemic Preconditioning in Diabetes

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16